In the wake of the increase in Current Liabilities in the third quarter 2023, Quick Ratio fell to 0.02 a new company low.

Within Medical Laboratories industry 49 other companies have achieved higher Quick Ratio than Akumin Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 2024 to 5330.

Explain Quick Ratio?
How much Cash & cash equivalents AKU�s has?
What are AKU�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AKU Quick Ratio	(Sep 30 2023) Q3	(Jun 30 2023) Q2	(Mar 31 2023) Q1	(Dec 31 2022) Q4	(Sep 30 2022) Q3
Y / Y Current Liabilities Change	587.35 %	-1.1 %	5.09 %	-22.85 %	30.28 %
Y / Y Cash & cash equivalent Change	-46.69 %	-1.25 %	12.81 %	22.73 %	6.23 %
Quick Ratio MRQ	0.02	0.19	0.22	0.31	0.28
AKU's Total Ranking	# 5330	# 2024	# 3172	# 3809	# 2912
Seq. Current Liabilities Change	646.55 %	-5.03 %	6.42 %	-8.91 %	7.42 %
Seq. Cash & cash equivalent Change	-16.66 %	-16.37 %	-23.6 %	0.11 %	54.38 %

Quick Ratio third quarter 2023 Company Ranking
Within:	No.
Medical Laboratories Industry	# 50
Healthcare Sector	# 1147
Overall Market	# 5330

Quick Ratio Statistics
High	Average	Low
1.77	0.4	0.02
(Dec 31 2020)		(Sep 30 2023)

Financial Statements
Akumin Inc 's Current Liabilities	$ 1,463 Millions	Visit AKU's Balance sheet
Akumin Inc 's Cash & cash equivalent	$ 32 Millions	Visit AKU's Balance sheet
Source of AKU's Sales		Visit AKU's Sales by Geography

Cumulative Akumin Inc 's Quick Ratio

AKU's Quick Ratio for the trailling 12 Months

AKU Quick Ratio	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months	(Mar 31 2023) 12 Months	(Dec 31 2022) 12 Months	(Sep 30 2022) 12 Months
Y / Y Current Liabilities TTM Growth	139.82 %	-0.02 %	27.51 %	68.86 %	284.75 %
Y / Y Cash & cash equivalent TTM Growth	-6.45 %	10.47 %	7.25 %	14.75 %	50.79 %
Quick Ratio TTM	0.08	0.25	0.25	0.25	0.22
Total Ranking TTM	# 4071	# 2391	# 5906	# 3855	# 3914
Seq. Current Liabilities TTM Growth	154.52 %	-0.27 %	1.25 %	-6.69 %	6.11 %
Seq. Cash & cash equivalent TTM Growth	-13.71 %	-0.24 %	2.61 %	5.9 %	1.9 %

Quick ratio ranking by company, industry and sector >> Back to AKU Financial Strength Comparisons >> Go to Compare AKU Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q3 2023 to $1,462.93 millions, cumulative Quick Ratio decreased to 0.08 below the Akumin Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 44 other companies have achieved higher Quick Ratio than Akumin Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 2391 to 4071.

Explain Quick Ratio?
How much Cash & cash equivalents AKU�s has?
What are AKU�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 45
Healthcare Sector	# 1091
Within the Market	# 4071

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.3	0.24	0.09
(Mar 31 2023)		(Sep 30 2023)

Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Medical Laboratories Industry	Quick Ratio	Sep 30 2023 MRQ Cash & cash equivalent	Sep 30 2023 MRQ Current Liabilities
Capforce Inc	0.02	$ 0.293 Millions	$ 12.472 Millions
Akumin Inc	0.02	$ 31.641 Millions	$ 1,462.934 Millions
Hh and l Acquisition Co	0.01	$ 0.123 Millions	$ 9.060 Millions
LUDWIG ENTERPRISES, INC.	0.00	$ 0.007 Millions	$ 1.356 Millions

Date modified: 2026-09-18T14:07:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.